[Malignant testicular neoplasms in the cisplatin era: causes of death and mortality in a cohort study]
- PMID: 35581422
- DOI: 10.1007/s00066-022-01957-8
[Malignant testicular neoplasms in the cisplatin era: causes of death and mortality in a cohort study]
Comment on
-
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort.J Clin Oncol. 2021 Nov 10;39(32):3561-3573. doi: 10.1200/JCO.21.00637. Epub 2021 Aug 13. J Clin Oncol. 2021. PMID: 34388002
References
Literatur
Verwendete Literatur
-
- Adams SC, DeLorey DS, Davenport MH, Farey AS, North S, Courneya KS (2018) Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. Br J Cancer 118:1313–1321 - DOI
-
- Chau C, Cahtomas R, Wheater M, Klingbiel D, Fehr M, Bennett J, Markham H, Lee C, Crabb SJ, Geldart T (2015) Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience. Ann Oncol 26:1865–1870 - DOI
-
- Einhorn LH, Donohue J (1977) Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87(3):293–298. https://doi.org/10.7326/0003-4819-87-3-293 - DOI - PubMed
-
- Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Stahl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Gillessen S (2017) Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma. J Clin Oncol 35:194–200 - DOI
-
- Fossa SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB (2007) Non-cancer causes of death in survivors of testicular cancer. J Natl Cancer Inst 99:533–544 - DOI
Weiterführende Literatur
-
- Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2019) S3-Leitlinie Diagnostik, Therapie und Nachsorge der Keimzelltumoren des Hodens, Kurzversion 1.0. https://www.leitlinienprogramm-onkologie.de/leitlinien/hodentumoren . Zugegriffen: 10. Apr. 2022 (AWMF-Registernummer: 043/049OL)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical